DK0833640T3 - Farmaceutisk præparat indeholdende lamotrigin - Google Patents
Farmaceutisk præparat indeholdende lamotriginInfo
- Publication number
- DK0833640T3 DK0833640T3 DK96923914T DK96923914T DK0833640T3 DK 0833640 T3 DK0833640 T3 DK 0833640T3 DK 96923914 T DK96923914 T DK 96923914T DK 96923914 T DK96923914 T DK 96923914T DK 0833640 T3 DK0833640 T3 DK 0833640T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- pharmaceutical preparation
- preparation containing
- lamotrigine
- containing lamotrigine
- Prior art date
Links
- PYZRQGJRPPTADH-UHFFFAOYSA-N lamotrigine Chemical compound NC1=NC(N)=NN=C1C1=CC=CC(Cl)=C1Cl PYZRQGJRPPTADH-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001848 lamotrigine Drugs 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000012931 lyophilized formulation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9512854.2A GB9512854D0 (en) | 1995-06-23 | 1995-06-23 | Novel formulation |
| PCT/EP1996/002759 WO1997000681A1 (en) | 1995-06-23 | 1996-06-20 | Pharmaceutical composition containing lamotrigine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0833640T3 true DK0833640T3 (da) | 2003-03-24 |
Family
ID=10776584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96923914T DK0833640T3 (da) | 1995-06-23 | 1996-06-20 | Farmaceutisk præparat indeholdende lamotrigin |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5942510A (da) |
| EP (1) | EP0833640B1 (da) |
| JP (1) | JPH11507936A (da) |
| AT (1) | ATE228844T1 (da) |
| AU (1) | AU6415796A (da) |
| DE (1) | DE69625200T2 (da) |
| DK (1) | DK0833640T3 (da) |
| ES (1) | ES2188766T3 (da) |
| GB (1) | GB9512854D0 (da) |
| PT (1) | PT833640E (da) |
| SI (1) | SI0833640T1 (da) |
| WO (1) | WO1997000681A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
| GB9812413D0 (en) * | 1998-06-10 | 1998-08-05 | Glaxo Group Ltd | Compound and its use |
| DK1169060T3 (da) * | 1999-04-09 | 2006-01-16 | Euro Celtique Sa | Natriumkanalblokkerpræparater og anvendelse deraf |
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| IL157608A0 (en) * | 2001-02-27 | 2004-03-28 | Teva Pharma | New crystal forms of lamotrigine and processes for their preparations |
| DK1423168T3 (da) * | 2001-09-03 | 2006-05-15 | Newron Pharm Spa | Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse |
| CA2483103A1 (en) * | 2002-04-23 | 2003-11-06 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing lamotrigine particles of defined morphology |
| DE10327674A1 (de) * | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
| DK1809271T5 (da) * | 2004-09-10 | 2010-12-06 | Newron Pharm Spa | Anvendelse af (R)-(halogenbenzyloxy)benzylaminopropanamider som natrium- og/eller calciumkanalselektive modulatorer |
| CA2615173C (en) | 2005-07-14 | 2012-01-03 | Lipothera, Inc. | Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
| US20120142919A1 (en) * | 2006-08-02 | 2012-06-07 | Medichem, S.A. | Method for synthesizing lamotrigine |
| US8486927B2 (en) * | 2007-11-09 | 2013-07-16 | Thar Pharmaceuticals | Crystalline forms of lamotrigine |
| US9132084B2 (en) | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
| GB2487868B (en) * | 2010-01-15 | 2014-12-10 | Neothetics Inc | Lyophilized cake formulations |
| UA111822C2 (uk) | 2010-11-24 | 2016-06-24 | Общєство С Огранічєнной Отвєтствєнностью "Новамедіка" | Монотерапевтичий препарат селективного ліпофільного бета-агоніста тривалої дії і спосіб косметичного лікування ожиріння і контурного випинання |
| CN104940128A (zh) * | 2015-05-31 | 2015-09-30 | 黑龙江佰彤儿童药物研究有限公司 | 一种拉莫三嗪口服液体制剂及其制备方法 |
| GB2641294A (en) | 2024-05-24 | 2025-11-26 | Novumgen Ltd | An orodispersible tablet of Lamotrigine and its process of preparation |
| US12605388B2 (en) * | 2024-09-25 | 2026-04-21 | Azurity Pharmaceuticals Ireland Limited | Lamotrigine salts, co-crystals, and compositions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK153787C (da) * | 1979-06-01 | 1989-01-16 | Wellcome Found | Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved |
| US4406888A (en) * | 1981-01-09 | 1983-09-27 | Pfizer Inc. | Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution |
| GB8613183D0 (en) * | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
| US5283067A (en) * | 1987-01-30 | 1994-02-01 | Ciba-Geigy Corporation | Parenteral suspensions |
| US5059619A (en) * | 1989-06-14 | 1991-10-22 | Quadra Logic Technologies, Inc. | Stable freeze-dried polyhematoporphyrin ether/ester |
| FR2699077B1 (fr) * | 1992-12-16 | 1995-01-13 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. |
| FR2702148B1 (fr) * | 1993-03-05 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement du neuro-sida. |
| FR2702149B1 (fr) * | 1993-06-03 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application de la lamotrigine dans le traitement du neuro-sida. |
| GB9317146D0 (en) * | 1993-08-18 | 1993-10-06 | Wellcome Found | Therapeutic combinations |
| JP3411038B2 (ja) * | 1993-09-15 | 2003-05-26 | シンテックス（ユー・エス・エイ）・インコーポレイテッド | ミコフェノール酸モフェチルの結晶質無水物およびその静注用製剤 |
| GB9424766D0 (en) * | 1994-12-07 | 1995-02-08 | Wellcome Found | Pharmaceutical composition |
| GB9426448D0 (en) * | 1994-12-30 | 1995-03-01 | Wellcome Found | Process |
| GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
-
1995
- 1995-06-23 GB GBGB9512854.2A patent/GB9512854D0/en active Pending
-
1996
- 1996-06-20 AT AT96923914T patent/ATE228844T1/de not_active IP Right Cessation
- 1996-06-20 DE DE69625200T patent/DE69625200T2/de not_active Expired - Fee Related
- 1996-06-20 AU AU64157/96A patent/AU6415796A/en not_active Abandoned
- 1996-06-20 WO PCT/EP1996/002759 patent/WO1997000681A1/en not_active Ceased
- 1996-06-20 DK DK96923914T patent/DK0833640T3/da active
- 1996-06-20 US US08/973,798 patent/US5942510A/en not_active Expired - Fee Related
- 1996-06-20 PT PT96923914T patent/PT833640E/pt unknown
- 1996-06-20 ES ES96923914T patent/ES2188766T3/es not_active Expired - Lifetime
- 1996-06-20 SI SI9630578T patent/SI0833640T1/xx unknown
- 1996-06-20 EP EP96923914A patent/EP0833640B1/en not_active Expired - Lifetime
- 1996-06-20 JP JP9503591A patent/JPH11507936A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SI0833640T1 (en) | 2003-08-31 |
| PT833640E (pt) | 2003-04-30 |
| ATE228844T1 (de) | 2002-12-15 |
| AU6415796A (en) | 1997-01-22 |
| EP0833640B1 (en) | 2002-12-04 |
| WO1997000681A1 (en) | 1997-01-09 |
| DE69625200D1 (de) | 2003-01-16 |
| JPH11507936A (ja) | 1999-07-13 |
| DE69625200T2 (de) | 2003-08-21 |
| GB9512854D0 (en) | 1995-08-23 |
| ES2188766T3 (es) | 2003-07-01 |
| US5942510A (en) | 1999-08-24 |
| EP0833640A1 (en) | 1998-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0833640T3 (da) | Farmaceutisk præparat indeholdende lamotrigin | |
| BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
| PT948527E (pt) | Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem | |
| DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| PT979244E (pt) | Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem | |
| EA199901015A1 (ru) | 4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а | |
| RU95106362A (ru) | Производные липопептида, способ их получения, содержащая их фармацевтическая композиция и способ ее получения | |
| ATE213940T1 (de) | Parenteral anzuwendende arzneizubereitung enthaltend amiodaron | |
| BR9509975A (pt) | Formulação farmacêutica | |
| BR9609847A (pt) | Derivados de N-(4-Benzila-substituída)-2-aminolactam | |
| BR9608472A (pt) | Uso de um composto preparação farmacêutica e processo para uso na profilaxa e/ou tratamento de sintomas dispépticos | |
| ATE233246T1 (de) | Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe | |
| ES2132383T3 (es) | Inhibidores de proteasa hiv. | |
| FI973184A7 (fi) | Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibi ittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdoll isesti yhdessä AZT:n, DDI:n tai DDC:n kanssa | |
| ATE213410T1 (de) | Diclofenac/gamma-cyclodextrin klathrat komponente | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| PT989994E (pt) | Derivados de estreptograminas, a sua preparacao e as composicoes que os contem | |
| DE69910787D1 (de) | Neuartige, pharmazeutisch aktive verbindung | |
| DK0805817T3 (da) | Thiolderivater med metallopeptidaseinhiberende aktivitet | |
| FR2700116B1 (fr) | Application d'anticonvulsivants comme radioprotecteurs. |